Clinical-Stage Platforms
Part of Biotech - Drug Development
 TMO | Thermo Fisher Scientific, Inc. | $242.1b | $687.41 | 0.0% | 231 |
 A | Agilent Technologies Inc. | $47.3b | $175.01 | -1.4% | 414 |
 IQV | IQVIA Holdings Inc. | $42.5b | $272.84 | +3.4% | 9.1K |
 WAT | Waters Corp | $41.8b | $448.38 | 0.0% | 6 |
 WST | West Pharmaceutical Services, Inc. | $25.7b | $396.86 | 0.0% | 156 |
 RPRX | Royalty Pharma plc Class A Ordinary Shares | $25.5b | $65.14 | 0.0% | 24.0K |
 RVTY | Revvity, Inc. | $16.9b | $160.40 | 0.0% | 2.1K |
 MEDP | Medpace Holdings, Inc. Common Stock | $16.7b | $679.95 | 0.0% | 26 |
 ASND | Ascendis Pharma A/S Ordinary Share | $15.0b | $245.88 | 0.0% | 53 |
 CRL | Charles River Laboratories International, Inc. | $13.9b | $355.89 | 0.0% | 414 |
 TWST | Twist Bioscience Corporation Common Stock | $12.5b | $146.35 | 0.0% | 2.1K |
 ICLR | Icon Plc | $12.5b | $184.03 | 0.0% | 52 |
 HALO | Halozyme Therapeutics, Inc. | $12.5b | $127.86 | 0.0% | 1.8K |
 TECH | Bio-Techne Corp. | $11.4b | $72.63 | 0.0% | 341 |
 AVTR | Avantor, Inc. | $10.4b | $17.45 | 0.0% | 1 |
 RGEN | Repligen Corp | $10.3b | $170.81 | 0.0% | 264 |
 BRKR | Bruker Corporation | $9.6b | $56.95 | 0.0% | 1.0K |
 QGEN | QIAGEN N.V. | $9.2b | $50.30 | -0.1% | 35.5K |
 KYMR | Kymera Therapeutics, Inc. Common Stock | $8.9b | $114.27 | 0.0% | 120 |
 LGND | Ligand Pharmaceuticals Inc. | $6.0b | $308.19 | 0.0% | N/A |
 CGON | CG Oncology, Inc. Common stock | $6.0b | $61.60 | 0.0% | 79 |
 KOD | Kodiak Sciences Inc Common Stock | $5.9b | $90.37 | 0.0% | 331 |
 MANE | Veradermics, Incorporated | $4.9b | $138.32 | -0.0% | 1.6K |
 ABCL | AbCellera Biologics Inc. Common Shares | $4.5b | $12.16 | 0.0% | 23.1K |
 RLAY | Relay Therapeutics, Inc. Common Stock | $4.2b | $18.05 | 0.0% | 6.2K |
 OGN | Organon & Co. | $3.6b | $13.77 | 0.0% | 36 |
 CELC | Celcuity Inc. Common Stock | $3.5b | $67.26 | 0.0% | 1.8K |
 NRIX | Nurix Therapeutics, Inc. Common stock | $2.4b | $25.93 | 0.0% | 2.3K |
 SLS | SELLAS Life Sciences Group, Inc. Common Stock | $2.4b | $11.43 | 0.0% | 14.3K |
 SDGR | Schrodinger, Inc. Common Stock | $2.3b | $25.02 | 0.0% | 36.5K |
 DAWN | Day One Biopharmaceuticals, Inc. Common Stock | $2.2b | $21.52 | -0.0% | 3.0M |
 RXRX | Recursion Pharmaceuticals, Inc. Class A Common Stock | $2.2b | $3.83 | 0.0% | 117.4K |
 TRVI | Trevi Therapeutics, Inc. Common Stock | $2.0b | $12.59 | 0.0% | 1.0K |
 ALVO | Alvotech Ordinary Shares | $1.9b | $4.61 | 0.0% | 411 |
 FTRE | Fortrea Holdings Inc. Common Stock | $1.9b | $23.93 | 0.0% | 63 |
 ABSI | Absci Corporation Common Stock | $1.9b | $9.61 | 0.0% | 19.2K |
 ZYME | Zymeworks Inc. | $1.8b | $28.63 | 0.0% | 278 |
 GENB | Generate Biomedicines, Inc. Common Stock | $1.8b | $12.46 | 0.0% | 13.4K |
 CERT | Certara, Inc. Common Stock | $1.4b | $10.63 | 0.0% | 23.8K |
 INBX | Inhibrx Biosciences, Inc. Common Stock | $1.4b | $88.50 | 0.0% | 1.9K |
 TYRA | Tyra Biosciences, Inc. Common Stock | $1.4b | $20.55 | 0.0% | 14.3K |
 MRVI | Maravai LifeSciences Holdings, Inc. Class A Common Stock | $1.2b | $7.63 | 0.0% | 8.2K |
 BCAX | Bicara Therapeutics Inc. Common Stock | $1.2b | $17.10 | 0.0% | 628 |
 OPK | Opko Health Inc. | $1.2b | $1.63 | 0.0% | 1.5K |
 HROW | Harrow, Inc. Common Stock | $1.1b | $29.45 | 0.0% | 4.2K |
 VOR | Vor Biopharma Inc. Common Stock | $1.1b | $18.25 | 0.0% | 394 |
 PCRX | Pacira BioSciences, Inc. Common Stock | $1.0b | $36.81 | 0.0% | 3.7K |
 GLUE | Monte Rosa Therapeutics, Inc. Common Stock | $0.9b | $10.79 | 0.0% | 7.9K |
 SANA | Sana Biotechnology, Inc. Common Stock | $0.9b | $2.38 | 0.0% | 6.8K |
 DNA | Ginkgo Bioworks Holdings, Inc. | $0.8b | $10.14 | +0.8% | 8.8K |